Page 140 - IJB-10-1
P. 140

International Journal of Bioprinting                                 Bioprinting organoids for toxicity testing






































                                              Figure 5. Processes of bioprinting a pancreas.

            important for clinical treatment and drug development. 53-56    literature. 69-73  In 2D cell culture, the cells are grown in a
            The traditional  in vivo drug screening model, such as   single layer attached to the bottom of a flat dish, while in
            patient-derived xenograft (PDX) animal model, involves   3D cells culture, the 3D structure of the cells is constructed
            high resource cost, long testing time, and ethical problems,   in a 3D scaffold. The advantages and disadvantages of both
            but the advent of bioprinting technology could resolve these   methods are presented in Table 2, while their differences
            problems. 57-60  Through bioprinting, highly reproducible   are depicted in Table 3. 2D cell culture is relatively simple,
            pancreatic cancer models that mimic tissue structure   easy to operate, and suitable for the study of cell growth and
            and microenvironment of human can be built  in vitro,   basic function. 74-77  However, it cannot simulate cell growth
            allowing for accurate evaluation of drug efficacy in in vitro   in the complex microenvironment in the body, resulting in
            environment and facilitating personalized treatment    distortion of cell morphology, function, and drug response.
                                                                                                            78
                                                         61
            Compared  with  the  traditional  PDX  animal  model,  the   In addition, the biology of the cells may change in 2D cell
            bioprinted PDX animal model is more accurate and   culture, affecting the reliability of the study. In contrast, 3D
            controllable, and can be customized for more targeted drug   cell culture could, at a greater extent, mimic the physiological
            screening according to the tumor characteristics of different   environment and is able to simulate cell interactions and
            patients (Figure 6). However, to execute in vitro evaluation of   signaling in stereoscopic structures. This allows for a more
            anti-pancreatic cancer drugs, bioprinted pancreatic cancer   accurate assessment of drug efficacy, tumor invasion, and
            models are required to accurately simulate a variety of   biological behavior.  However, the process of 3D cell culture
                                                                              79
            biological characteristics, such as tumor cell growth, spread,   necessitates high technical requirements, in terms of the
            and drug response, which requires more in-depth cellular   selection of scaffold materials, cell arrangement, and the fine
            and biological studies. 62-69  In addition, the standardization   control of the construction process.
            and industrialization of bioprinting technology still need to     80-83
            be further promoted to achieve wider applications.    Several studies   have constructed 3D models with
                                                               microstructural characteristics that simulate pancreatic
            4.2. Comparison of 2D and 3D cell culture          islets and tumors  in vitro through bioprinting. This
            in vitro models                                    technological  breakthrough  is  a  clear  indicator  that  in
            The differences between two-dimensional (2D) cell culture   vitro models created with 3D culture could make up for
            and 3D cell culture models, as well as their respective   the shortcomings of traditional 2D cell culture (Figure 7).
            advantages and disadvantages, have been analyzed in the   Through cell orientation and scaffold design, a more


            Volume 10 Issue 1 (2024)                       132                          https://doi.org/10.36922/ijb.1256
   135   136   137   138   139   140   141   142   143   144   145